Dana reported Q1 sales beat, affirming FY24 guidance amid efficiency gains. Company-wide efficiency improvements continue to offset the margin impact of inflation and spending on development for electric-vehicle products, Dana said.
Gainers
Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire the company for $3.25 per share in cash.